Skip to main content

Creating a treatment plan that works.

-

 

Starting treatment for Duchenne may feel like entering unknown territory. By creating a treatment plan up front, you can help make the experience more comfortable for your child and less stressful for you. Let’s talk about a few options you should discuss with your doctor when creating a treatment plan that will work for your family. And remember, your SareptAssist Case Manager is ready to provide information on any questions that come up.

Questions?

Give us a call.

Logo for SareptAssist, the patient support program for EXONDYS 51 patients

1-888-SAREPTA

1-888-727-3782
Case Managers are available Monday – Friday
8:30am – 6:30pm ET

Where to get treatment.

EXONDYS 51 treatment is a weekly infusion that is always given by a trained healthcare provider. You may be wondering how that works. Depending on your doctor’s instructions, insurance plan coverage, and your own preferences, your child’s infusions will take place in one of these locations:

At an infusion center.

A medical clinic that specializes in infusions. These facilities provide infusion services for a variety of medications and are staffed with nurses and technicians who are well versed in performing infusions. 

At home.

Performed by an experienced nurse. You may have the option of in-home infusions, where the nurse comes to you and your child can remain at home. Ask your child's doctor about their recommendation.

At a doctor’s office.

Medical facilities equipped to offer infusions. Your doctor’s office or local hospital may be equipped to perform outpatient infusions. Talk to your doctor about what they recommend.

Allergic reactions, including rash, hives, fever, flushing, cough, difficulty breathing, wheezing, and low blood pressure have occurred in patients who were treated with EXONDYS 51. Seek immediate medical care if signs and symptoms of allergic reactions occur.

Considerations:

  • Your doctor’s recommendation. What does your doctor say about infusing at a center vs. infusing at home?
  • Time and convenience. You’ll need to block out time for your infusion. Call ahead to ask your nurse or doctor what to expect.
  • Coverage. Every insurance plan is different, so be sure to connect with your SareptAssist Case Manager if you have questions about which infusion locations are covered by your plan.

EXONDYS 51 patient Ryan, age 11, seated in wheelchair smiling and looking at camera

EXONDYS 51 patient Ryan, age 11, seated in wheelchair smiling and looking at camera

 

When to schedule treatment.

It’s important to keep your therapy schedule as consistent as possible. Try to choose a day and time that you’ll be able to keep, week in and week out.

What about vacation?

Let your Case Manager know if you’re planning a trip. There may be an option to arrange an infusion at your destination to keep your treatment schedule on track. 

Calendar

 

-

 

How to choose: An IV or a port?

EXONDYS 51 is given by a weekly intravenous (IV) infusion, which is a method of delivering medicine directly into your bloodstream through a vein. This is typically done through a temporary IV that is inserted before and removed after treatment, or through a port, which is implanted in the chest or arm and remains in the body. Discuss your options with your child's doctor.

Questions?

Give us a call.

Logo for SareptAssist, the patient support program for EXONDYS 51 patients

1-888-SAREPTA

1-888-727-3782
Case Managers are available Monday – Friday
8:30am – 6:30pm ET

“When I got closer to starting infusions, I didn’t really know what to expect. SareptAssist was helpful and I got the answers I needed.”

–Ash, EXONDYS 51 patient

Headshot of EXONDYS 51 patient Ash, age 21, with trees in backgound
Meet Ash, age 21. Deletion of exons 48-50.
Meet Ash, age 21. Deletion of exons 48-50.

Related FAQs

What is SareptAssist?

SareptAssist is our patient support program. Families are connected with dedicated Case Managers who provide information and support to help them start and stay on treatment with EXONDYS 51. How SareptAssist can help.

What happens if I miss an infusion?

Talk to your healthcare provider. If you miss a dose of EXONDYS 51, it may be administered as soon as possible after the scheduled time.

See All FAQs

WHAT IS EXONDYS 51® (eteplirsen)?

EXONDYS 51 is used to treat Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation in the dystrophin gene that can be treated by skipping exon 51.

EXONDYS 51 was approved under accelerated approval. Accelerated approval allows for drugs to be approved based on a marker that is considered reasonably likely to predict a clinical benefit that has not been proven. EXONDYS 51 treatment increased the marker, dystrophin, in skeletal muscle in some patients. Verification of a clinical benefit may be needed for EXONDYS 51 to continue to be approved.

IMPORTANT RISK INFORMATION

Allergic reactions, including rash, hives, fever, flushing, cough, difficulty breathing, wheezing, and low blood pressure have occurred in patients who were treated with EXONDYS 51. Seek immediate medical care if signs and symptoms of allergic reactions occur.

Side effects that happened at least 25% more often in 8 patients treated with EXONDYS 51 by intravenous infusion than in 4 patients treated with an inactive intravenous infusion were problems with balance (38%, 0%), vomiting (38%, 0%), and skin irritation (25%, 0%). The most common side effects were problems with balance and vomiting.

In patients who received EXONDYS 51 for up to 4 years in clinical studies, the following side effects were reported in at least 10% of patients and occurred more often than at the same dose of EXONDYS 51: vomiting, bruising, scratches, joint pain, rash, IV site pain, and infections of the upper airways.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. You may also report side effects to Sarepta Therapeutics at 1-888-SAREPTA (1-888-727-3782).

READ MORE

WHAT IS EXONDYS 51® (eteplirsen)?

EXONDYS 51 is used to treat Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation in the dystrophin gene that can be treated by skipping exon 51.

EXONDYS 51 was approved under accelerated approval. Accelerated approval allows for drugs to be approved based on a marker that is considered reasonably likely to predict a clinical benefit that has not been proven. EXONDYS 51 treatment increased the marker, dystrophin, in skeletal muscle in some patients. Verification of a clinical benefit may be needed for EXONDYS 51 to continue to be approved.

IMPORTANT RISK INFORMATION

Allergic reactions, including rash, hives, fever, flushing, cough, difficulty breathing, wheezing, and low blood pressure have occurred in patients who were treated with EXONDYS 51. Seek immediate medical care if signs and symptoms of allergic reactions occur.

Side effects that happened at least 25% more often in 8 patients treated with EXONDYS 51 by intravenous infusion than in 4 patients treated with an inactive intravenous infusion were problems with balance (38%, 0%), vomiting (38%, 0%), and skin irritation (25%, 0%). The most common side effects were problems with balance and vomiting.

In patients who received EXONDYS 51 for up to 4 years in clinical studies, the following side effects were reported in at least 10% of patients and occurred more often than at the same dose of EXONDYS 51: vomiting, bruising, scratches, joint pain, rash, IV site pain, and infections of the upper airways.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. You may also report side effects to Sarepta Therapeutics at 1-888-SAREPTA (1-888-727-3782).

Please see the full Prescribing Information for EXONDYS 51 (eteplirsen).